4//SEC Filing
Sullivan Timothy Eugene 4
Accession 0001127602-25-002385
CIK 0001492422other
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 12:15 PM ET
Size
5.7 KB
Accession
0001127602-25-002385
Insider Transaction Report
Form 4
Sullivan Timothy Eugene
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-01-29$29.52/sh−546$16,120→ 128,665 total
Holdings
- 70,396(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 28, 2025.
- [F2]The securities are held by The Timothy E Sullivan Irrevocable Trust of 2023. Patrick O. Collins is the trustee of The Timothy E Sullivan Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Timothy E Sullivan Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001707000
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 12:15 PM ET
- Size
- 5.7 KB